Max Ludwig Ahnen

Max Ludwig Ahnen is Co-Founder of Positrigo, an ETH Zurich spin-off pioneering ultra-compact brain PET imaging technology, where he served in roles spanning CEO, COO, and Chief Science Officer over nearly seven years.
Max holds a Doctor of Sciences from ETH Zurich and a Diplom-Physiker degree from the Technical University of Munich, developing deep expertise in particle physics that he translated directly into medical imaging innovation.
Max co-developed the BPET clinical prototype within ETH Zurich's Institute for Particle Physics and Astrophysics, and led Positrigo through regulatory milestones, clinical trials, and multiple funding rounds, earning the Venture Kick Stage I, II, and III awards totaling CHF 130,000.
At Positrigo, Max navigated the full MedTech journey from whiteboard to certified product, collaborating with University Hospital Zurich and securing backing from the European Innovation Council, 4FO Ventures, and Zurich Cantonal Bank.
Positrigo raised $18.2M across nine funding rounds and developed NeuroLF, a brain PET scanner one-fifth the size and one-tenth the cost of traditional systems, aiming to make early Alzheimer's diagnosis accessible to hospitals worldwide.